000 | 01822 a2200517 4500 | ||
---|---|---|---|
005 | 20250515063413.0 | ||
264 | 0 | _c20070501 | |
008 | 200705s 0 0 fre d | ||
022 | _a1773-0597 | ||
024 | 7 |
_a10.1016/s0181-5512(07)89584-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaudouin, C | |
245 | 0 | 0 |
_a[A new approach for better comprehension of diseases of the ocular surface]. _h[electronic resource] |
260 |
_bJournal francais d'ophtalmologie _cMar 2007 |
||
300 |
_a239-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBlepharitis _xcomplications |
650 | 0 | 4 |
_aConjunctiva _xpathology |
650 | 0 | 4 |
_aConjunctivitis, Allergic _xcomplications |
650 | 0 | 4 |
_aContact Lenses _xadverse effects |
650 | 0 | 4 |
_aCornea _xpathology |
650 | 0 | 4 |
_aCorneal Ulcer _xetiology |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 |
_aDry Eye Syndromes _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLacrimal Apparatus _xinnervation |
650 | 0 | 4 |
_aLacrimal Apparatus Diseases _xcomplications |
650 | 0 | 4 |
_aLipids _xanalysis |
650 | 0 | 4 |
_aMeibomian Glands _xmetabolism |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNeurogenic Inflammation _xcomplications |
650 | 0 | 4 |
_aOphthalmic Solutions _xadverse effects |
650 | 0 | 4 | _aOsmolar Concentration |
650 | 0 | 4 |
_aPostoperative Complications _xetiology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aRosacea _xcomplications |
650 | 0 | 4 |
_aSjogren's Syndrome _xcomplications |
650 | 0 | 4 | _aSurface Properties |
650 | 0 | 4 |
_aTears _xchemistry |
650 | 0 | 4 | _aWettability |
773 | 0 |
_tJournal francais d'ophtalmologie _gvol. 30 _gno. 3 _gp. 239-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0181-5512(07)89584-2 _zAvailable from publisher's website |
999 |
_c16968775 _d16968775 |